Literature DB >> 10468096

Frequency and prognostic significance of pericardial effusion in primary pulmonary hypertension. PPH Study Group. Primary pulmonary hypertension.

A L Hinderliter1, P W Willis, W Long, W R Clarke, D Ralph, E J Caldwell, W Williams, N A Ettinger, N S Hill, W R Summer, B de Biosblanc, G Koch, S Li, L M Clayton, M M Jöbsis, J W Crow.   

Abstract

Pericardial effusion was noted in 43 of 79 patients (54%) with severe primary pulmonary hypertension. Larger effusion was associated with hemodynamic and echocardiographic evidence of right heart failure, impaired exercise tolerance, and a poor 1-year prognosis.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10468096     DOI： 10.1016/s0002-9149(99)00342-2

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


  24 in total

Review 1.  Redefining the role of cardiovascular imaging in patients with pulmonary arterial hypertension.

Authors:  Benjamin H Freed; Amit R Patel; Roberto M Lang
Journal:  Curr Cardiol Rep       Date:  2012-06       Impact factor: 2.931

Review 2.  Surrogate end points in pulmonary arterial hypertension: assessing the response to therapy.

Authors:  Jennifer L Snow; Steven M Kawut
Journal:  Clin Chest Med       Date:  2007-03       Impact factor: 2.878

3.  Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension.

Authors:  Micah R Fisher; Paul R Forfia; Elzbieta Chamera; Traci Housten-Harris; Hunter C Champion; Reda E Girgis; Mary C Corretti; Paul M Hassoun
Journal:  Am J Respir Crit Care Med       Date:  2009-01-22       Impact factor: 21.405

4.  Management of Right Ventricular Failure in Pulmonary Hypertension (and After LVAD Implantation).

Authors:  Brittany Palmer; Brent Lampert; Michael A Mathier
Journal:  Curr Treat Options Cardiovasc Med       Date:  2013-10

5.  The ratio of the atrial areas reflects the clinical status of patients with pulmonary arterial hypertension.

Authors:  Takashi Morishita; Katsumasa Miyaji; Izumi Akao; Keiji Fujita; Hiromi Nakayama; Kenichi Hisamatsu; Mitsuru Munemasa; Yoshihisa Fujimoto; Hiromi Matsubara
Journal:  J Med Ultrason (2001)       Date:  2009-08-15       Impact factor: 1.314

Review 6.  [Diagnostics in pulmonary hypertension].

Authors:  M Leschke; A Wädlich; S Waldenmaier; M Faehling
Journal:  Internist (Berl)       Date:  2009-09       Impact factor: 0.743

7.  Effect of imatinib as add-on therapy on echocardiographic measures of right ventricular function in patients with significant pulmonary arterial hypertension.

Authors:  Amil M Shah; Patricia Campbell; Gabriela Querejeta Rocha; Andrew Peacock; Robyn J Barst; Debbie Quinn; Scott D Solomon
Journal:  Eur Heart J       Date:  2014-02-23       Impact factor: 29.983

Review 8.  The right ventricle under pressure: evaluating the adaptive and maladaptive changes in the right ventricle in pulmonary arterial hypertension using echocardiography (2013 Grover Conference series).

Authors:  Alexis Harrison; Nathan Hatton; John J Ryan
Journal:  Pulm Circ       Date:  2015-03       Impact factor: 3.017

9.  Echocardiographic assessment of estimated right atrial pressure and size predicts mortality in pulmonary arterial hypertension.

Authors:  Christopher Austin; Khadija Alassas; Charles Burger; Robert Safford; Ricardo Pagan; Katherine Duello; Preetham Kumar; Tonya Zeiger; Brian Shapiro
Journal:  Chest       Date:  2015-01       Impact factor: 9.410

10.  Beneficial and adverse effects of bosentan treatment in korean patients with pulmonary artery hypertension.

Authors:  Dae-Won Sohn; Hyung-Kwan Kim; Myung-A Kim; Yeong-Wook Song; Chung-Il Noh; Duk-Kyung Kim; I-Seok Kang; Hojoong Kim; Sang-Do Lee; Young-Hwue Kim; Ho-Joong Youn; Namsik Chung; Jae-Young Choi; Jae-Bum Jun; Jinho Shin
Journal:  Korean Circ J       Date:  2009-03-25       Impact factor: 3.243
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.